- Home
- FISV vs BNTX Comparison
FISV vs BNTX Comparison
Compare FISV & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FISV | BNTX |
|---|---|---|
| Founded | 1984 | 2008 |
| Country | United States | Germany |
| Employees | 38000 | N/A |
| Industry | Real Estate | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 28.7B | 24.2B |
| IPO Year | N/A | 2019 |
Fundamental Metrics
Financial Performance| Metric | FISV | BNTX |
|---|---|---|
| Price | $51.91 | $94.60 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 28 | 13 |
| Target Price | ★ $146.17 | $133.46 |
| AVG Volume (30 Days) | ★ 8.5M | 988.2K |
| Earning Date | 05-05-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $3.94 | $3.37 |
| P/E Ratio | $9.94 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $47.04 | $79.81 |
| 52 Week High | $70.41 | $124.00 |
Technical Indicators
Market Signals| Indicator | FISV | BNTX |
|---|---|---|
| Relative Strength Index (RSI) | 50.78 | 56.20 |
| Support Level | $47.04 | $90.95 |
| Resistance Level | $64.56 | $112.93 |
| Average True Range (ATR) | 1.96 | 2.32 |
| MACD | 0.57 | 0.82 |
| Stochastic Oscillator | 79.71 | 59.04 |
Price Performance
Historical ComparisonAbout FISV Fiserv Inc.
Fiserv is a leading provider of core processing and complementary services, such as electronic funds transfer, payment processing, and loan processing, for US banks and credit unions, with a focus on small and midsize banks. Following its 2019 merger with First Data, Fiserv also provides payment processing services to merchants. About 10% of the company's revenue is generated internationally.
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens and neoantigens; monospecific and bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.